• Startseite
• russia
• Clarivate to Cease all Commercial Activity in Russia - Clarivate

Clarivate to Cease all Commercial Activity in Russia - Clarivate

4.8 (688) · € 23.99 · Auf Lager

Clarivate Reports Fourth Quarter and Full Year 2022 Results - Clarivate

slide11.jpg

Biopharma Commercial Analytics & Effectiveness

Scientific collaboration with Russia begins to unravel

Acquisition of the Thomson Reuters Intellectual Property and Science Business by Onex and Baring Asia Completed

Web of Science platform - Clarivate

Research Analytics & Management Systems - Clarivate

slide06.jpg

Jonathan Gear Become Chief Executive Officer at Clarivate with Jerre Stead Retirement